SIG Brokerage’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.78M Sell
1,487
-1,988
-57% -$2.03M 0.03% 358
2026
Q1
$3.2M Buy
3,475
+1,258
+57% +$1.28M 0.08% 196
2025
Q4
$2.38M Buy
2,217
+1,563
+239% +$1.49M 0.07% 207
2025
Q3
$499K Buy
654
+230
+54% +$171K 0.01% 519
2025
Q2
$331K Buy
+424
New +$329K 0.01% 547
2025
Q1
Sell
-585
Closed -$487K 645
2024
Q4
$452K Buy
+585
New +$484K 0.02% 346

Other funds holding LLY

SIG Brokerage's LLY Position: Q2 2026 in Review

SIG Brokerage reduced its Eli Lilly (LLY) stake by 57% in Q2 2026, selling an estimated $2.03M and leaving 1,487 shares worth $1.78M. The position accounts for 0.03% of the portfolio, ranked #358.

SIG Brokerage first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.2M in Q1 2026. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • SIG Brokerage held 1,487 shares of Eli Lilly worth $1.78M as of Q2 2026.
  • SIG Brokerage sold 1,988 Eli Lilly shares in Q2 2026, an estimated $2.03M.
  • Eli Lilly made up 0.03% of SIG Brokerage's portfolio in Q2 2026, its #358 holding.
  • SIG Brokerage first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • SIG Brokerage's Eli Lilly position peaked at $3.2M in Q1 2026.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on SIG Brokerage's 13F filing for Q2 2026, filed 14 Aug 2026.